Skip to main content
Watch Insiders
ABTHealthcare

Abbott Laboratories (ABT) Insider Trading

In the last 90 days, 3 Abbott Laboratories (ABT) insiders reported no open-market purchases and 3 sales totaling $46,850,270. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 2, 2026John A. Mccoy Jr.VICE PRESIDENT AND CONTROLLERSale27$109.54$2,958
Aug 25, 2026Robert B FordCHAIRMAN AND CEOSale398,832$115.85$46,204,807
Aug 11, 2026Louis H. MorroneEXECUTIVE VICE PRESIDENTSale5,850$109.83$642,506
May 7, 2026John G StrattonDirectorOpen Market Purchase2,000$86.82$173,640
Apr 27, 2026Daniel J StarksDirectorOpen Market Purchase10,000$92.65$926,537
Apr 23, 2026Philip P BoudreauEVP AND CFOOpen Market Purchase2,200$91.50$201,300

Common questions

ABT insider trading FAQ

Are ABT insiders buying or selling?
Over the last 90 days, ABT insiders were net sellers, reporting $0.00 of open-market purchases and $46,850,270 of sales.
When was the last ABT insider purchase?
No open-market insider purchase of Abbott Laboratories stock was reported in the last 90 days.
Where does ABT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Abbott Laboratories officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.